切换至 "中华医学电子期刊资源库"

第五届中国出版政府奖音像电子网络出版物奖提名奖

中国科技核心期刊

中国科学引文数据库(CSCD)来源期刊

中华重症医学电子杂志 ›› 2016, Vol. 02 ›› Issue (04) : 273 -276. doi: 10.3877/cma.j.issn.2096-1537.2016.04.011

所属专题: 重症医学 文献

观点

急性呼吸窘迫综合征:我选择体外膜肺氧合
顾思超1, 夏金根1, 李敏1, 易丽1, 詹庆元1,()   
  1. 1. 100029 北京, 卫生计生委中日友好医院呼吸与危重症医学科
  • 收稿日期:2016-11-04 出版日期:2016-11-28
  • 通信作者: 詹庆元
  • 基金资助:
    国家重点研发计划项目(2016YFC1304300); 国家自然青年科学基金项目(81401629); 首都临床特色应用研究与成果推广项目(Z161100000516116)

To treat acute respiratory distress syndrome: I prefer extracorporeal membrane oxygenation

Sichao Gu1, Jingen Xia1, Min Li1, Li Yi1, Qingyuan Zhan1,()   

  1. 1. Department of Respiratory and Critical Care Medicine, China-Japan Friendship Hospital, Beijing 100029, China
  • Received:2016-11-04 Published:2016-11-28
  • Corresponding author: Qingyuan Zhan
  • About author:
    Corresponding author: Zhan Qingyuan, Email:
引用本文:

顾思超, 夏金根, 李敏, 易丽, 詹庆元. 急性呼吸窘迫综合征:我选择体外膜肺氧合[J/OL]. 中华重症医学电子杂志, 2016, 02(04): 273-276.

Sichao Gu, Jingen Xia, Min Li, Li Yi, Qingyuan Zhan. To treat acute respiratory distress syndrome: I prefer extracorporeal membrane oxygenation[J/OL]. Chinese Journal of Critical Care & Intensive Care Medicine(Electronic Edition), 2016, 02(04): 273-276.

急性呼吸窘迫综合征(acute respiratory distress syndrom,ARDS)是临床常见危重症,目前多采用保护性肺通气策略,但部分患者仍难以纠正低氧血症及高碳酸血症,或并发气压伤,病死率居高不下。体外膜肺氧合(extracorporeal membrane oxygenation,ECMO)能够完全或部分替代心肺功能,应用于重度ARDS具有诸多优势,包括减少呼吸机相关肺损伤、纠正低氧血症、辅助撤机等,真正做到"肺休息" 。虽然应用ECMO的预后仍不十分确切,治疗的风险和费用较高,但随着各项技术的进步与经验的积累,ECMO的应用必将有更广阔的前景。

Acute respiratory distress syndrome (ARDS) is a common clinical critical illness, which is usually treated with lung protective ventilation stratagy. It?s still difficult to correct hypoxemia and hypercapnia in some severe patients, who are also prone to barotrauma and have a higher mortality rate. Extracorporeal membrane oxygenation (ECMO) can completely or partially support cardiopulmonary function, showing many advantages in treating severe ARDS, such as reducing ventilator induced lung injury, correcting hypoxemia and assisting weaning. Although there is no certainty with the outcome of ECMO patients and ECMO brings about a higher treatment risk and cost, the application of ECMO still shows a more broad prospect with improvement of technique and accumulation of experiences.

[1]
Sheu CC, Gong MN, Zhai R, et al. The influence of infection sites on development and mortality of ARDS[J]. Intensive Care Medicine, 2010, 36(6): 963-970.
[2]
Muller T, Philipp A, Luchner A, et al. A new miniaturized system for extracorporeal membrane oxygenation in adult respiratory failure[J]. Crit Care, 2009, 13(6): 1-10.
[3]
Ney L, Kuebler WM. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury[J]. N Engl J Med, 2000, 343(11): 813.
[4]
Zambon M, Vincent JL. Mortality rates for patients with acute lung injury/ARDS have decreased over time[J]. Chest, 2008, 133(5): 1120-1127.
[5]
Hill JD, OʹBrien TG, Murray JJ, et al. Prolonged extracorporeal oxygenation for acute post-traumatic respiratory failure (shock-lung syndrome). Use of the Bramson membrane lung[J]. N Engl J Med, 1972, 286(12): 629-634.
[6]
Mugford M, Elbourne D, Field D. Extracorporeal membrane oxygenation for severe respiratory failure in newborn infants[J]. Cochrane Db Syst rev, 2008, 1(1): 50-51.
[7]
Gattinoni L, Carlesso E, Langer T. Clinical review: extracorporeal membrane oxygenation[J]. Crit care, 2011, 15(6): 243.
[8]
Peek GJ, Mugford M, Tiruvoipati R, et al. Efficacy and economic assessment of conventional ventilatory support versus extracorporeal membrane oxygenation for severe adult respiratory failure (CESAR): a multicentre randomised controlled trial[J]. Lancet, 2009, 374(9698): 1351-1363.
[9]
Van Kaam AH, Rimensberger PC. Lung-protective ventilation strategies in neonatology: what do we know--what do we need to know?[J]. Crit Care Med, 2007, 35(3): 925-931.
[10]
Petrucci N, Lacovelli W. Lung protective ventilation strategy for the acute respiratory distress syndrome[J]. Cochrane Db Syst rev, 2007, 2(3): CD003844.
[11]
Needham DM, Colantuoni E, Mendez-Tellez PA, et al. Lung protective mechanical ventilation and two year survival in patients with acute lung injury: prospective cohort study[J]. BMJ, 2012, 344(7): e2124.
[12]
Terragni PP, Rosboch GL, Lisi A, et al. How respiratory system mechanics may help in minimising ventilator-induced lung injury in ARDS patients[J]. Eur Respir J Suppl., 2003, 42(2): 15s-21s.
[13]
Bein T, Weber-Carstens S, Goldmann A, et al. Lower tidal volume strategy ( approximately 3 ml/kg) combined with extracorporeal CO2 removal versus ʹconventionalʹ protective ventilation (6 ml/kg) in severe ARDS: the prospective randomized Xtravent-study[J]. Intensive Care Medicine, 2013, 39(5): 847-856.
[14]
Amato MB, Meade MO, Slutsky AS, et al. Driving pressure and survival in the acute respiratory distress syndrome[J]. N Engl J Med, 2015, 372(8): 747-755.
[15]
Terragni P, Faggiano C, Ranieri VM. Extracorporeal membrane oxygenation in adult patients with acute respiratory distress syndrome[J]. Curr Opin Crit Care, 2014, 20(1): 86-91.
[16]
Lim CM, Soon LS, Seoung LJ, et al. Morphometric effects of the recruitment maneuver on saline-lavaged canine lungs -a computed tomographic analysis[J]. Anesthesiology, 2003, 99(1): 71-80.
[17]
Mekontso Dessap A, Charron C, Devaquet J, et al. Impact of acute hypercapnia and augmented positive end-expiratory pressure on right ventricle function in severe acute respiratory distress syndrome[J]. Intensive Care Medicine, 2009, 35(11): 1850-1858.
[18]
Zapol WM, Snider MT, Hill JD, et al. Extracorporeal membrane oxygenation in severe acute respiratory failure. A randomized prospective study[J]. JAMA, 1979, 242(20): 2193-2196.
[19]
Morris AH, Wallace CJ, Menlove RL, et al. Randomized clinical trial of pressure-controlled inverse ratio ventilation and extracorporeal CO2 removal for adult respiratory distress syndrome[J]. Am J Res Crit Care Med, 1994, 149(2 Pt 1): 295-305.
[20]
The Australia and New Zealand Extracorporeal Membrane Oxygenation (ANZ ECMO) Influenza Investigators. Extracorporeal Membrane Oxygenation for 2009 Influenza A(H1N1) Acute Respiratory Distress Syndrome[J]. Yearbook of Anesthesiology and Pain Management, 2009, 302(17): 1888-1895.
[21]
Bryner B, Cooley E, Copenhaver W, et al. Two decadesʹ experience with interfacility transport on extracorporeal membrane oxygenation[J]. Ann Thorac Surg, 2014, 98(4): 1363-1370.
[22]
Pranikoff T, Hirschl RB, Remenapp R, et al. Venovenous extracorporeal life support via percutaneous cannulation in 94 patients[J]. Chest, 1999, 115(3): 818-822.
[23]
Marasco SF, Lukas G, McDonald M, McMillan J, Ihle B. Review of ECMO (extra corporeal membrane oxygenation) support in critically ill adult patients[J]. Heart Lung and Circulation, 2008, 17(Suppl 4): S41-S47.
[24]
Schuerer DJ, Kolovos NS, Boyd KV, et al. Extracorporeal membrane oxygenation: current clinical practice, coding, and reimbursement[J]. Chest, 2008, 134(1): 179-184.
[25]
Brodie D, Bacchetta M. Extracorporeal membrane oxygenation for ARDS in adults[J]. N Engl J Med, 2011, 365(20): 1905-1914.
[1] 江雅婷, 刘林峰, 沈辰曦, 陈奔, 刘婷, 龚裕强. 组织相关巨噬素3 保护肺血管内皮糖萼治疗急性呼吸窘迫综合征的机制研究[J/OL]. 中华危重症医学杂志(电子版), 2024, 17(05): 353-362.
[2] 李振翮, 魏长青, 甄国栋, 李振富. 脓毒症并发急性呼吸窘迫综合征患者血清S1P、Wnt5a变化及其临床意义[J/OL]. 中华危重症医学杂志(电子版), 2024, 17(04): 293-300.
[3] 杨茂宪, 沈鹏, 王倩倩, 吴旺, 沈永帅, 蒋禛, 徐龙生, 朱建刚, 刘倍倍. 吡啶甲酸镁联合地塞米松对急性呼吸窘迫综合征大鼠的治疗作用研究[J/OL]. 中华危重症医学杂志(电子版), 2024, 17(03): 196-203.
[4] 李智, 冯芸. NF-κB 与MAPK 信号通路及其潜在治疗靶点在急性呼吸窘迫综合征中的研究进展[J/OL]. 中华肺部疾病杂志(电子版), 2024, 17(05): 840-843.
[5] 魏丁, 乔艳艳, 顾兴, 张燕, 李艳燕, 钱卫生, 潘蕾, 高永恒, 金发光. 体外膜肺氧合救治急性呼吸窘迫综合征不良预后危险因素分析[J/OL]. 中华肺部疾病杂志(电子版), 2024, 17(03): 363-367.
[6] 王晓霞, 乌丹, 张江英, 乌雅罕, 郝颖楠, 斯日古楞. 《2023 年美国胸科学会关于成人急性呼吸窘迫综合征患者管理的临床实践指南更新》解读[J/OL]. 中华重症医学电子杂志, 2024, 10(04): 338-343.
[7] 杨东星, 沈鹏, 赵慧颖. 免疫球蛋白联合依库珠单抗治疗GBS 并发重度ARDS 患者一例[J/OL]. 中华重症医学电子杂志, 2024, 10(04): 404-408.
[8] 倪韫晖, 杨毅, 袁雪燕, 邱海波. 胸壁加压在急性呼吸窘迫综合征中的应用和临床进展[J/OL]. 中华重症医学电子杂志, 2024, 10(03): 243-247.
[9] 杨永红, 杨莹, 齐红蕾, 刘福瑞, 朱金源. 单细胞测序在急性呼吸窘迫综合征中的应用进展[J/OL]. 中华重症医学电子杂志, 2024, 10(03): 248-252.
[10] 李松栗, 黄蔚, 巢杰, 杨毅, 邱海波. 单核/巨噬细胞来源的细胞外囊泡在急性呼吸窘迫综合征中的研究进展[J/OL]. 中华重症医学电子杂志, 2024, 10(03): 253-257.
[11] 田学, 谢晖, 王瑞兰. 急性呼吸窘迫综合征相关肺纤维化的研究进展[J/OL]. 中华重症医学电子杂志, 2024, 10(03): 258-264.
[12] 刘悦, 潘纯. 急性呼吸窘迫综合征患者肌松剂滴定的必要性与可行性[J/OL]. 中华重症医学电子杂志, 2024, 10(02): 108-112.
[13] 王永广, 朱鹏, 许千金, 甘桂芬, 石钟山, 潘纯. 急性呼吸窘迫综合征诊断标准亟需更新[J/OL]. 中华重症医学电子杂志, 2024, 10(02): 113-117.
[14] 史楠, 袁雪燕, 邱海波. 肺复张在急性呼吸窘迫综合征中的应用和临床进展[J/OL]. 中华重症医学电子杂志, 2024, 10(02): 118-126.
[15] 詹维强, 李梦蝶, 涂玉玲, 郭艳, 芦乙滨, 史新格, 许明. 早期CRRT联合VA-ECMO治疗难治性心源性休克的临床效果[J/OL]. 中华卫生应急电子杂志, 2024, 10(05): 260-268.
阅读次数
全文


摘要


AI


AI小编
你好!我是《中华医学电子期刊资源库》AI小编,有什么可以帮您的吗?